Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,896,948
+$967,481 QoQ
Shares Held
3,249
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.52%
of 13F equity value
Holder Rank
#1,908
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Certified Advisory Corp holds $12,736,081 across 8 Drug Manufacturers - General names. LLY ranks #2 (30.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,212 | $4,117,361 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
3,249 | $3,896,948 | |
| 3 | ABBV |
AbbVie Inc.
|
7,683 | $1,933,350 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,732 | $850,520 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,383 | $820,215 | |
| 6 | AMGN |
Amgen Inc
|
1,762 | $638,055 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,692 | $270,353 | |
| 8 | PFE |
Pfizer Inc
|
8,691 | $209,279 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,896,948 | 3,249 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,929,467 | 3,185 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,588,356 | 3,339 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,546,894 | 3,338 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,864,772 | 3,675 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,984,838 | 3,614 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,115,792 | 4,036 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,627,924 | 4,095 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,679,464 | 4,064 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,051,159 | 3,922 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,290,875 | 3,930 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,126,316 | 37,194 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,762,895 | 3,759 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,307,056 | 3,806 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,291,781 | 3,531 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,162,766 | 3,596 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,154,583 | 3,561 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,019,763 | 3,561 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $983,343 | 3,560 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $862,971 | 3,735 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $863,224 | 3,761 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $55,111 | 295 | Shares | Sole | 2021-05-10 | |
| 2020-06-30 | $37,104 | 226 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $31,212 | 225 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||